Quartz Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Quartz Partners's NVS Position: Q1 2026 in Review
Quartz Partners reduced its Novartis (NVS) stake by 1.1% in Q1 2026, selling an estimated $59.5K and leaving 34,994 shares worth $5.35M. The position accounts for 2.07% of the portfolio, ranked #13.
Quartz Partners first reported a position in NVS in Q3 2024 and has held it in 7 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Quartz Partners held 34,994 shares of Novartis worth $5.35M as of Q1 2026.
- Quartz Partners sold 388 Novartis shares in Q1 2026, an estimated $59.5K.
- Novartis made up 2.07% of Quartz Partners's portfolio in Q1 2026, its #13 holding.
- Quartz Partners first reported a position in Novartis in Q3 2024 and has held it in 7 quarters since.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Quartz Partners's 13F filing for Q1 2026, filed 5 May 2026.